Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    OnKure Therapeutics Inc.

    NASDAQ: OKUR · Real-Time Price · USD
    2.40
    -0.12 (-4.76%)
    At close: Jun 27, 2025, 3:59 PM
    2.40
    0.00%
    After-hours: Jun 27, 2025, 04:04 PM EDT

    OnKure Therapeutics Statistics

    Share Statistics

    OnKure Therapeutics has 13.51M shares outstanding. The number of shares has increased by null% in one year.

    Shares Outstanding

    n/a
    		 13.51M

    Shares Change (YoY)

    n/a
    		 n/a

    Shares Change (QoQ)

    n/a
    		 n/a

    Owned by Institutions (%)

    n/a
    		 n/a

    Shares Floating

    n/a
    		 n/a

    Failed to Deliver (FTD) Shares

    n/a
    		 9,260

    FTD / Avg. Volume

    n/a
    		 5.84%

    Short Selling Information

    The latest short interest is 530.27K, so 3.92% of the outstanding shares have been sold short.

    Short Interest

    n/a
    		 530.27K

    Short % of Shares Out

    n/a
    		 3.92%

    Short % of Float

    n/a
    		 5.58%

    Short Ratio (days to cover)

    n/a
    		 2.04

    Valuation Ratios

    The PE ratio is -2.18 and the forward PE ratio is -0.74. OnKure Therapeutics's PEG ratio is -0.04.

    PE Ratio

    n/a
    		 -2.18

    Forward PE

    n/a
    		 -0.74

    PS Ratio

    n/a
    		 0

    Forward PS

    n/a
    		 n/a

    PB Ratio

    n/a
    		 1.1

    P/FCF Ratio

    n/a
    		 -2.24

    PEG Ratio

    n/a
    		 -0.04
    Financial Ratio History

    Enterprise Valuation

    Currently the Enterprise Value (EV) is not available for OnKure Therapeutics.

    EV / Sales

    n/a
    		 n/a

    EV / EBITDA

    n/a
    		 n/a

    EV / EBIT

    n/a
    		 n/a

    EV / FCF

    n/a
    		 n/a

    Financial Position

    The company has a current ratio of 10.73, with a Debt / Equity ratio of 0.01.

    Current Ratio

    n/a
    		 10.73

    Quick Ratio

    n/a
    		 10.73

    Debt / Equity

    n/a
    		 0.01

    Debt / EBITDA

    n/a
    		 -0.02

    Debt / FCF

    n/a
    		 -0.02

    Interest Coverage

    n/a
    		 -181.29

    Financial Efficiency

    Return on Equity is n/a and Return on Invested Capital is n/a.

    Return on Equity

    n/a
    		 n/a

    Return on Assets

    n/a
    		 n/a

    Return on Invested Capital

    n/a
    		 n/a

    Revenue Per Employee

    n/a
    		 n/a

    Profits Per Employee

    n/a
    		 $-1,145,065.22

    Employee Count

    n/a
    		 46

    Asset Turnover

    n/a
    		 0

    Inventory Turnover

    n/a
    		 n/a

    Taxes

    Income Tax

    n/a
    		 n/a

    Effective Tax Rate

    n/a
    		 0%

    Stock Price Statistics

    The stock price has increased by -84.29% in the last 52 weeks. The beta is 0.42, so OnKure Therapeutics's price volatility has been higher than the market average.

    Beta

    n/a
    		 0.42

    52-Week Price Change

    n/a
    		 -84.29%

    50-Day Moving Average

    n/a
    		 2.48

    200-Day Moving Average

    n/a
    		 8.5

    Relative Strength Index (RSI)

    n/a
    		 47.32

    Average Volume (20 Days)

    n/a
    		 158,659

    Income Statement

    Revenue

    n/a
    		 n/a

    Gross Profit

    n/a
    		 n/a

    Operating Income

    n/a
    		 -54.39M

    Net Income

    n/a
    		 -52.67M

    EBITDA

    n/a
    		 -51.71M

    EBIT

    n/a
    		 -52.37M

    Earnings Per Share (EPS)

    n/a
    		 -3.95
    Full Income Statement

    Balance Sheet

    The company has 110.76M in cash and 1.08M in debt, giving a net cash position of 109.68M.

    Cash & Cash Equivalents

    n/a
    		 110.76M

    Total Debt

    n/a
    		 1.08M

    Net Cash

    n/a
    		 109.68M

    Retained Earnings

    n/a
    		 -154.72M

    Total Assets

    n/a
    		 99.88M

    Working Capital

    n/a
    		 89.39M
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was -51.12M and capital expenditures -52K, giving a free cash flow of -51.17M.

    Operating Cash Flow

    n/a
    		 -51.12M

    Capital Expenditures

    n/a
    		 -52K

    Free Cash Flow

    n/a
    		 -51.17M

    FCF Per Share

    n/a
    		 -3.84
    Full Cash Flow Statement

    Margins

    Gross Margin

    n/a
    		 n/a

    Operating Margin

    n/a
    		 n/a

    Pretax Margin

    n/a
    		 n/a

    Profit Margin

    n/a
    		 n/a

    EBITDA Margin

    n/a
    		 n/a

    EBIT Margin

    n/a
    		 n/a

    FCF Margin

    n/a
    		 n/a

    Dividends & Yields

    OKUR does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 n/a

    FCF Yield

    n/a
    		 n/a
    Dividend Details

    Analyst Forecast

    The average price target for OKUR is $32.5, which is 1184.6% higher than the current price. The consensus rating is "Buy".

    Price Target

    n/a
    		 $32.5

    Price Target Difference

    n/a
    		 1184.6%

    Analyst Consensus

    n/a
    		 Buy

    Analyst Count

    n/a
    		 4
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 n/a

    Graham Upside

    n/a
    		 n/a

    Stock Splits

    The last stock split was on Oct 7, 2024. It was a backward split with a ratio of 1:10.

    Last Split Date

    n/a
    		 Oct 7, 2024

    Split Type

    n/a
    		 backward

    Split Ratio

    n/a
    		 1:10

    Scores

    Altman Z-Score

    n/a
    		 -1.3

    Piotroski F-Score

    n/a
    		 2

    Add to Watchlist